Pulmonary Eosinophilia - 20 Studies Found

Active, not recruiting : Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients
: Asthma
: 2016-01-11
:
  • Drug: Mepolizumab 100mg SC At

Completed : A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma
: Eosinophils, Asthma
: 2017-02-07
: Drug: reslizumab 110-mg
Completed : Efficacy, Safety, and Tolerability of SAR231893 (REGN668) in Patients With Persistent Moderate to Severe Eosinophilic Asthma
: Asthma
: 2011-03-09
:
  • Biological: SAR231893 (REGN668)

Enrolling by invitation : Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma
:
  • Severe Persistent Asthma
  • Eosinophilic Bronchitis

: 2015-09-22
:
  • Biological: Reslizumab Reslizu
Completed : Study of Mepolizumab Autoinjector in Asthmatics
: Asthma
: 2017-03-29
: Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio
Active, not recruiting : Study of Mepolizumab Safety Syringe in Asthmatics
: Asthma
: 2017-01-12
: Drug: Mepolizumab It is a clear to opalescent, colorless to pale yellow sterile solution for SC injectio
Active, not recruiting : Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
: Asthma
: 2015-02-26
: Drug: Mepolizumab Mepolizumab is supplied as 100 mg lyophilised cake in sterile vials for subcutaneous a
Completed : An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation
: Asthma
: 2016-10-14
:
  • Drug: Reslizumab Administered

Completed : Small Particle Steroids in Refractory Asthma
: Asthma
: 2010-06-24
:
  • Drug: Ciclesonide Inhaled cicl
Active, not recruiting : A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
: Asthma
: 2014-05-08
:
  • Biological: Mepolizumab Mepoli
<<< Previous